Trials / Terminated
TerminatedNCT00704782
Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease
An Open-Label Extension Study of Combination Therapy With Dimebon and Donepezil in Patients With Alzheimer's Disease
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Medivation, Inc. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of Dimebon in combination with donepezil (Aricept) in the treatment of Alzheimer's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dimebon |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2008-06-25
- Last updated
- 2015-12-10
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00704782. Inclusion in this directory is not an endorsement.